Quintiles, the world’s leading biopharmaceutical services company, and
Through a co-promotion agreement covering Europe and the United
This alliance is the first of its kind in the industry. Kadrige and Quintiles’ joint offering provides the full continuum of services and solutions required to evolve smoothly from an aging promotional model to a new one, based on the smart mix of multiple channels of communication that will bring to the biotech or pharma company, cost reductions, sales impact increase and a much larger flexibility to react to market evolutions.
“With Kadrige, we can revolutionize the lifecycle implementation of a brand by customizing physician detailing in accordance with its lifecycle need,” said Michael Ackermann, Senior Vice President of Commercialization for Quintiles. “We are committed to helping our customers succeed in the New Health, and these innovative hybrid call center and multichannel models are the transformative solutions our customers require.”
“While many companies are piloting a hybrid approach, our agreement with Quintiles provides a real-world solution that saves customers time and money by delivering the right message at the right time to the right target through the right channel,” Kadrige Founder and Chairman Olivier Cadou said. “This agreement expands our presence in the U.S. and Europe through access to the largest biotech and pharma sales force in the world.”